Top Markets
Coin of the day
Anew Medical, Inc. Anew Medical, Inc.

Anew Medical, Inc.

WENA
Classifica tra le azioni #33463
Anew Medical, Inc. is a biopharmaceutical firm dedicated to developing... Anew Medical, Inc. is a biopharmaceutical firm dedicated to developing innovative treatments for conditions affecting the brain and nervous system, age-related illnesses, and specialized diagnostic tools. Their pipeline includes advanced cell and gene therapies specifically designed to alleviate symptoms of aging-related conditions, such as dementia, Alzheimer's disease, and various neuromuscular disorders. Additionally, Anew Medical is engaged in developing biologics and biosimilars for cancer treatment, alongside research into therapies targeting melanocortin receptors. A key strategic alliance exists with Japan's Okinawa Research Center, focusing on the collaborative research and development of Klotho gene therapy. This initiative aims to extend human longevity and diminish the impact of age-related diseases. The company maintains its headquarters in Omaha, Nebraska.
Prezzo delle azioni
$0.5099
Ultima sincronizzazione: 2024-10-15
Capitalizzazione di mercato
$7.60M
Variazione (1 giorno)
2.02%
Variazione (1 anno)
0.00%
Paese
US
Scambia Anew Medical, Inc. (WENA)

Categoria

EPS per Anew Medical, Inc. (WENA)
EPS al June 2024 TTM: $0.00
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Anew Medical, Inc., l’EPS attuale della società (TTM) è $0.00. Alla fine del 2022, la società aveva un EPS di $0.08 un aumento rispetto a rispetto a quello del 2021, che era di $-0.09.
Storico EPS per Anew Medical, Inc. da 2021 a 2026
EPS alla fine di ogni anno
Anno EPS Cambia
2026 (TTM) 0.00 -102.64%
2023 $0.14 69.29%
2022 $0.08 -196.73%
2021 $-0.09 0.00%
EPS per aziende simili o concorrenti
Azienda EPS Differenza di EPS Il paese
$17.32 -468,208.11%
US
$27.74 -749,829.73%
NL
- -
CH
- -
KR
$13.70 -370,372.97%
BE